Notably, researchers conducting a whole-exome and whole-transcriptome profiling study identified not only higher frequencies of BRCA1/2 mutation in younger Korean patients with BC tumours, but also enrichment of a mutation signature linked to homologous recombination repair (HRR) deficiency in triple-negative BC (TNBC)11. This evidence concerns the gene BRCA1 and breast cancer.